836 related articles for article (PubMed ID: 25762939)
21. Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome.
Gibney SM; Gosselin RD; Dinan TG; Cryan JF
Neuroscience; 2010 Feb; 165(3):675-83. PubMed ID: 19765638
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity.
Russell JP; Mohammadi E; Ligon CO; Johnson AC; Gershon MD; Rao M; Shen Y; Chan CC; Eidam HS; DeMartino MP; Cheung M; Oliff AI; Kumar S; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2019 Feb; 368(2):299-307. PubMed ID: 30413627
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.
Chen L; Ilham SJ; Feng B
Anesth Pain Med; 2017 Apr; 7(2):e42747. PubMed ID: 28824858
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.
Tsang SW; Auyeung KK; Bian ZX; Ko JK
Curr Neuropharmacol; 2016; 14(8):842-856. PubMed ID: 27009115
[TBL] [Abstract][Full Text] [Related]
25. Early-life stress induces visceral hypersensitivity in mice.
Moloney RD; O'Leary OF; Felice D; Bettler B; Dinan TG; Cryan JF
Neurosci Lett; 2012 Mar; 512(2):99-102. PubMed ID: 22326388
[TBL] [Abstract][Full Text] [Related]
26. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.
Farzaei MH; Bahramsoltani R; Abdollahi M; Rahimi R
J Neurogastroenterol Motil; 2016 Oct; 22(4):558-574. PubMed ID: 27431236
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Stress-induced Visceral Pain.
Meerveld BG; Johnson AC
J Neurogastroenterol Motil; 2018 Jan; 24(1):7-18. PubMed ID: 29291604
[TBL] [Abstract][Full Text] [Related]
28. Revisiting concepts of visceral nociception in irritable bowel syndrome.
Keszthelyi D; Troost FJ; Simrén M; Ludidi S; Kruimel JW; Conchillo JM; Masclee AA
Eur J Pain; 2012 Nov; 16(10):1444-54. PubMed ID: 22504901
[TBL] [Abstract][Full Text] [Related]
29. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models.
Barreau F; Ferrier L; Fioramonti J; Bueno L
Pediatr Res; 2007 Sep; 62(3):240-5. PubMed ID: 17622962
[TBL] [Abstract][Full Text] [Related]
30. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
[TBL] [Abstract][Full Text] [Related]
31. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
[TBL] [Abstract][Full Text] [Related]
32. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
33. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
Dupont HL
Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
35. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents.
Taché Y; Million M; Nelson AG; Lamy C; Wang L
Gend Med; 2005 Sep; 2(3):146-54. PubMed ID: 16290887
[TBL] [Abstract][Full Text] [Related]
36. Impact of psychological stress on irritable bowel syndrome.
Qin HY; Cheng CW; Tang XD; Bian ZX
World J Gastroenterol; 2014 Oct; 20(39):14126-31. PubMed ID: 25339801
[TBL] [Abstract][Full Text] [Related]
37. Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats.
Takajo T; Tomita K; Tsuchihashi H; Enomoto S; Tanichi M; Toda H; Okada Y; Furuhashi H; Sugihara N; Wada A; Horiuchi K; Inaba K; Hanawa Y; Shibuya N; Shirakabe K; Higashiyama M; Kurihara C; Watanabe C; Komoto S; Nagao S; Kimura K; Miura S; Shimizu K; Hokari R
Gut Liver; 2019 May; 13(3):325-332. PubMed ID: 30602220
[TBL] [Abstract][Full Text] [Related]
38. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
[TBL] [Abstract][Full Text] [Related]
39. Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity.
Lowén MB; Mayer E; Tillisch K; Labus J; Naliboff B; Lundberg P; Thorell LH; Ström M; Engström M; Walter S
Neurogastroenterol Motil; 2015 May; 27(5):646-55. PubMed ID: 25777251
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Mechanisms in Irritable Bowel Syndrome.
Mahurkar-Joshi S; Chang L
Front Psychiatry; 2020; 11():805. PubMed ID: 32922317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
